VIEW PDF 17 MAR 2020: Independence, OH – Great Lakes NeuroTechnologies The United States Patent Office issued a notice of allowance and awarded Great Lakes NeuroTechnologies (GLNT) patent claims in application 16/108,746 covering a therapy and diagnostic device combination for…
Blog Archives
Great Lakes NeuroTechnologies Introduces KinesiaU™ for Objective Motor Assessment Using a Smartwatch
VIEW PDF 02 May 2019: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it will be introducing the KinesiaU™ motor assessment system [ https://www.KinesiaU.com ] at the American Academy of Neurology Annual Meeting, which is being held in…
Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson’s disease starting transdermal rotigotine patch: A pilot study
Isaacson S, Boroojerdi B, Waln O, McGraw M, Kreitzman D, Klos K, Revilla F, Heldman D, Phillips M, Terricabras D, Markowitz M, Woltering F, Carson S, Truong D Parkinsonism & Related Disorders. 2019 (In Press)
Great Lakes NeuroTechnologies Awarded Two New Patents for Movement Disorders Therapy Adjustment
VIEW PDF 15 OCT 2018: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it has been awarded two new U.S. Patents. The new patents include 10,085,689 (Device and method for monitoring and assessment of movement disorder symptoms) issued…
The impact of a wearable device on Parkinson’s disease motor symptom management in patients starting rotigotine transdermal patch
S. Isaacson, B. Boroojerdi, K. Klos, S. Carson, M. Markowitz, D. Heldman, M. Phillips, D. Terricabras, F. Woltering, D. Truong. Movement Disorders Society Annual Meeting, 2018, Hong Kong.
Great Lakes NeuroTechnologies Receives Two New NIH SBIR Grant Awards
VIEW PDF 1 OCT 2018: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it has been awarded two new Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH), which will provide nearly $2 Million…
Using Objective Measurement Via Wearable Sensors To Evaluate Real-world Effectiveness Of Carbidopa/Levodopa Enteral Suspension For Managing Motor Fluctuations: PROviDE Study Design And Baseline Characteristics
R. Pahwa, R. Dorsey, I. Pan, S. van Norman, T. Marshall, D. Heldman, Y. Jalundhwala. 70th Annual Meeting of the American Academy of Neurology, Los Angeles, CA, 2018
Wearable Motion Quantification and Electronic Diaries for Long-Term Monitoring of Parkinson’s Disease
A. Hadley, E. Urrea-Mendoza, N. Mennucci, C. Zimmerman, J. Giuffrida, Z. Mari, M. Burack, I. Itin, F. Revilla, D. Heldman. 70th Annual Meeting of the American Academy of Neurology, Los Angeles, CA, 2018
Great Lakes NeuroTechnologies Wins Patent on Using Cell Phones and Smart Watches to Help Treat Parkinson’s Disease
VIEW PDF 08 DEC 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) received another Notice of Allowance for a new patent covering the use of cell phones and watches to analyze movement disorders such as Parkinson’s disease. The new…
App-Based Bradykinesia Tasks for Clinic and Home Assessment in Parkinson’s Disease: Reliability and Responsiveness
Heldman DA, Urrea-Mendoza E, Lovera LC, Schmerler DA, Garcia X, Mohammad ME, McFarlane MCU, Giuffrida JP, Espay AJ, Fernandez HH. J Parkinsons Dis. 2017;7(4):741-747.